TuHURA Biosciences, Inc. (HURA)

NASDAQ: HURA · Real-Time Price · USD

4.790

+0.060 (1.27%)

At close: Jan 17, 2025, 4:00 PM

4.990

+0.200 (4.18%)

After-hours: Jan 17, 2025, 6:24 PM EST

TuHURA Biosciences Employees

TuHURA Biosciences had 1 employees as of December 31, 2023.

Employees

1

Change

n/a

Growth

n/a

Revenue / Employee

n/a

Profits / Employee

-$19,333,782

Market Cap

201.32M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	1	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	122,000
Abbott Laboratories	114,000
AstraZeneca	89,900
Novartis AG	76,057
Merck & Co.	72,000
Novo Nordisk	64,319

Employee Rankings

HURA News

4 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders - GlobeNewsWire
5 weeks ago - TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc. - Accesswire
2 months ago - TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update - Accesswire
3 months ago - TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - Accesswire
3 months ago - TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event - Accesswire
3 months ago - TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Accesswire
3 months ago - Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 - PRNewsWire
3 months ago - Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences - PRNewsWire